The use of the murine model of infection with Leishmania major to reveal the antagonistic effects that IL-4 can exert on T helper cell development and demonstrate that these opposite effects depend upon the nature of the cells targeted for IL-4 signaling

Pathologie Biologie

Volumn 51, Issue 2, 2003, Pages 71-73

  Louis, J A ^a   Gumy, A ^a   Voigt, H ^a   Launois, P ^a   Rocken, M ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dendritic cells; Interleukine 4; Leischmania major infection; Th1 Th2 responses

Indexed keywords

ANTIGEN; EPITOPE; INTERLEUKIN 12; INTERLEUKIN 4; LACK ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL MATURATION; CONFERENCE PAPER; HELPER CELL; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; MOUSE STRAIN; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0037357645     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00101-9     Document Type: Conference Paper

References (14)

1. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Ann Rev Immunol 1995;13:151-77.
2. + effector cells default to the Th2 pathway in interferon gammadeficient mice infected with Leishmania major. J Exp Med 1994;179:1367-71.
3. + T cell response. J Exp Med 1995;181:961-71.
4. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody, evidence for a T cell-dependent, interferon-? independent mechanism. J Exp Med 1990;171:115-27.
5. + T cells which are NK1. Eur J Immunol 1995;1(; 25):3298-307.
6. Mougneau E, Altore F, Wakil AE, Zheng S, Coppela T, Wang Z-E, et al. Expression cloning of a protective Leishmania antigen. Science 1995;268:563-6.
7. + T cells in BALB/c mice infected with Leishmania major instructs Th2 cell development and susceptibility to infection. Immunity 1997;6:541-9.
8. Julia V, Rassoulzadegan M, Glaichenhaus N. Resistance to Leishmania major induced by tolerance to a single antigen. Science 1996;274:421-3.
9. Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM, et al. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol 2000;164:4819-25.
10. Pingel S, Launois P, Fowell DJ, Turck CW, Southwood S, Sette A, et al. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope. J Exp Med 1999;189:1111-20.
11. Noben-Trauth N, Kropf P, Muller I. Susceptibility to Leishmania major interleukin 4-deficient mice. Science 1996;271:987-90.
12. Schuller T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med 1999;189:803-10.
13. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont R, Maraskovsky E, et al. Interleukin 4 is a major cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 2000;192:823-33.
14. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, et al. Interleukin-4 instructs Th1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nature Immunol 2001;2:1054-60.